Tenofovir (PMPA), an acyclic nucleoside phosphonate analog, is one of the most important drugs used for the HIV treatment. Unfortunately, several adverse reactions are related to its i.v. administration owing to the saturation of an anionic renal transporter. In order to improve the drug administration, the PMPA was embedded into a new type of nanocarriers based on poly-(d,l-lactide-co-glycolide) (PLGA) and/or chitosan (CH). The strategies for the preparation of nanoparticles (Nps) with a more efficient drug loading respect to the one reported in the literature for PMPA nanoencapsulation were investigated. CH was added in the first inner emulsion or in the external phase during the second emulsion of water/oil/water (W/O/W) Nps. The addition of CH in the first inner emulsion was the most promising technique. The Nps have a Z-average of 230 nm, a Z-potential of −3 mV and an EE% of 15 that was 2.5–3 times higher than that obtained with PLGA Nps or CH Nps. In vitro release studies showed a limited control on drug release in phosphate buffer (pH 7.4) while an initial burst effect followed by a slow drug release was observed in acidic receiving phase (pH 4.6). These results suggest the PLGA/CH Nps should be an effective and attractive anti-HIV drug carrier to study the cellular uptake and drug delivery on target cells such as macrophages.

Chemico-physical investigation of tenofovir loaded polymeric nanoparticles / Belletti, Daniela; Tosi, Giovanni; Forni, Flavio; Gamberini, Maria Cristina; Baraldi, Cecilia; Vandelli, Maria Angela; Ruozi, Barbara. - In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. - ISSN 0378-5173. - STAMPA. - 436:(2012), pp. 753-763. [10.1016/j.ijpharm.2012.07.070]

Chemico-physical investigation of tenofovir loaded polymeric nanoparticles

BELLETTI, Daniela;TOSI, Giovanni;FORNI, Flavio;GAMBERINI, Maria Cristina;BARALDI, Cecilia;VANDELLI, Maria Angela;RUOZI, Barbara
2012

Abstract

Tenofovir (PMPA), an acyclic nucleoside phosphonate analog, is one of the most important drugs used for the HIV treatment. Unfortunately, several adverse reactions are related to its i.v. administration owing to the saturation of an anionic renal transporter. In order to improve the drug administration, the PMPA was embedded into a new type of nanocarriers based on poly-(d,l-lactide-co-glycolide) (PLGA) and/or chitosan (CH). The strategies for the preparation of nanoparticles (Nps) with a more efficient drug loading respect to the one reported in the literature for PMPA nanoencapsulation were investigated. CH was added in the first inner emulsion or in the external phase during the second emulsion of water/oil/water (W/O/W) Nps. The addition of CH in the first inner emulsion was the most promising technique. The Nps have a Z-average of 230 nm, a Z-potential of −3 mV and an EE% of 15 that was 2.5–3 times higher than that obtained with PLGA Nps or CH Nps. In vitro release studies showed a limited control on drug release in phosphate buffer (pH 7.4) while an initial burst effect followed by a slow drug release was observed in acidic receiving phase (pH 4.6). These results suggest the PLGA/CH Nps should be an effective and attractive anti-HIV drug carrier to study the cellular uptake and drug delivery on target cells such as macrophages.
2012
436
753
763
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles / Belletti, Daniela; Tosi, Giovanni; Forni, Flavio; Gamberini, Maria Cristina; Baraldi, Cecilia; Vandelli, Maria Angela; Ruozi, Barbara. - In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. - ISSN 0378-5173. - STAMPA. - 436:(2012), pp. 753-763. [10.1016/j.ijpharm.2012.07.070]
Belletti, Daniela; Tosi, Giovanni; Forni, Flavio; Gamberini, Maria Cristina; Baraldi, Cecilia; Vandelli, Maria Angela; Ruozi, Barbara
File in questo prodotto:
File Dimensione Formato  
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles.pdf

Solo gestori archivio

Tipologia: Versione pubblicata dall'editore
Dimensione 1.25 MB
Formato Adobe PDF
1.25 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/815492
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 23
social impact